Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for prevention of colistin-associated acute kidney injury
IRCT20130917014693N15Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of magnesium sulfate and colistin in acute kidney failure (AKF) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Occurrence of acute kidney injury, Serum creatinine and 1 more. Started Jan 2023; status: completed.
02
Drugs
magnesium sulfatecolistin
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on IRCT20130917014693N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130917014693N15.